Bret Taback Selected Research

Bret Taback Research Topics

Disease

25	Neoplasms (Cancer) 01/2022 - 01/2002
18	Melanoma (Melanoma, Malignant) 01/2021 - 10/2003
17	Breast Neoplasms (Breast Cancer) 01/2022 - 04/2003
6	Neoplasm Metastasis (Metastasis) 11/2020 - 03/2004
6	Disease Progression 01/2018 - 04/2003
4	Renal Cell Carcinoma (Grawitz Tumor) 01/2017 - 10/2007
3	Lymphedema (Milroy Disease) 01/2022 - 10/2015
3	Colorectal Neoplasms (Colorectal Cancer) 12/2008 - 09/2004
2	Pathologic Complete Response 10/2018 - 10/2014
2	Chromosome Aberrations (Chromosome Abnormalities) 06/2004 - 06/2004
1	Hypertension (High Blood Pressure) 01/2022
1	Seroma 01/2022
1	Opioid-Related Disorders (Opiate Addiction) 01/2022
1	Interstitial Lung Diseases (Interstitial Lung Disease) 11/2020
1	Merkel Cell Carcinoma 11/2020
1	Neuroendocrine Tumors (Neuroendocrine Tumor) 11/2020
1	Noninfiltrating Intraductal Carcinoma (DCIS) 01/2019
1	Brain Neoplasms (Brain Tumor) 01/2018
1	Abscess 01/2017
1	Residual Neoplasm 01/2017
1	Overweight 05/2014
1	Vaccinia 01/2009
1	Neoplasm Micrometastasis 09/2004

Drug/Important Bio-Agent (IBA)

6	DNA (Deoxyribonucleic Acid)IBA 09/2006 - 05/2004
5	Biomarkers (Surrogate Marker)IBA 01/2021 - 06/2004
4	Interleukin-2 (IL2)IBA 01/2018 - 01/2009
4	Messenger RNA (mRNA)IBA 01/2012 - 03/2004
4	AntigensIBA 01/2009 - 10/2003
4	Cell-Free Nucleic AcidsIBA 06/2004 - 01/2004
3	ParaffinIBA 07/2004 - 10/2003
2	taxaneIBA 01/2022 - 10/2018
2	IpilimumabIBA 01/2021 - 01/2018
2	Eosine Yellowish-(YS) (Eosin)IBA 01/2021 - 09/2004
2	Hematoxylin (Haematoxylon)IBA 01/2021 - 09/2004
2	VemurafenibIBA 01/2018 - 12/2017
2	talimogene laherparepvecIBA 01/2018 - 12/2016
2	Estrogen ReceptorsIBA 01/2012 - 03/2005
2	Proteins (Proteins, Gene)FDA Link 06/2009 - 05/2004
2	Nucleic AcidsIBA 09/2006 - 06/2004
2	Genetic Markers (Genetic Marker)IBA 09/2006 - 04/2003
2	Circulating Tumor DNAIBA 09/2006 - 01/2004
2	Calcibiotic Root Canal SealerIBA 09/2006 - 09/2004
2	RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA 07/2004 - 03/2004
2	RNA (Ribonucleic Acid)IBA 06/2004 - 06/2004
1	Opioid Analgesics (Opioids)IBA 01/2022
1	aldesleukin (Proleukin)FDA Link 01/2021
1	3- acetoxy- 1,11,12- dolabell- 4,8,18- trien- 16- al (ADTA)IBA 01/2021
1	Programmed Cell Death 1 ReceptorIBA 11/2020
1	Cytidine Diphosphate (CDP)IBA 10/2019
1	Doxorubicin (Adriamycin)FDA LinkGeneric 10/2018
1	pembrolizumabIBA 01/2018
1	NivolumabIBA 01/2018
1	HLA-DR Antigens (HLA-DR)IBA 01/2018
1	Codon (Codons)IBA 12/2017
1	Hemoglobins (Hemoglobin)IBA 01/2017
1	Anti-Bacterial Agents (Antibiotics)IBA 01/2017
1	Biological ProductsIBA 10/2014
1	Hormones (Hormone)IBA 10/2014
1	Metformin (Glucophage)FDA LinkGeneric 05/2014
1	Cetuximab (Erbitux)FDA Link 10/2013
1	CytokinesIBA 10/2007
1	Tumor Biomarkers (Tumor Markers)IBA 09/2006
1	Coloring Agents (Dyes)IBA 08/2006
1	Radioisotopes (Radionuclides)IBA 08/2006
1	ErbB Receptors (EGF Receptor)IBA 03/2005
1	Peptide Nucleic AcidsIBA 09/2004
1	MART-1 AntigenIBA 07/2004
1	TransferasesIBA 07/2004
1	Transcription Factor 3IBA 07/2004
1	Apoptotic Protease-Activating Factor 1IBA 06/2004
1	Tretinoin (Retinoic Acid)FDA LinkGeneric 05/2004
1	O-(6)-methylguanineIBA 05/2004
1	Death-Associated Protein KinasesIBA 05/2004
1	Monophenol Monooxygenase (Tyrosinase)IBA 10/2003
1	tyrosinase-related protein-1IBA 10/2003
1	dopachrome isomeraseIBA 10/2003

Therapy/Procedure

9	Therapeutics 01/2021 - 01/2004
8	Drug Therapy (Chemotherapy) 01/2022 - 03/2004
6	Immunotherapy 01/2021 - 10/2007
5	Radiotherapy 12/2021 - 03/2004
5	Lymph Node Excision (Lymph Node Dissection) 10/2018 - 03/2004
5	Neoadjuvant Therapy 01/2017 - 10/2013
4	Segmental Mastectomy (Lumpectomy) 01/2022 - 08/2006
3	Mastectomy (Mammectomy) 01/2022 - 01/2017
1	Mammaplasty (Breast Reconstruction) 01/2019
1	Lasers (Laser) 01/2002